In part 2 of our video series with drug market experts Luke Turnock, PhD, and Jenny Markell, we explored social media advertisements for prescription drugs and how they may impact patients.
Providing people with the ability to test for viruses in their own homes empowers them to be proactive about their health while helping public health officials, policymakers, and researchers with information that could head off the next pandemic.
Overall median survival was higher in participants taking quizartinib, according to results from QuANTUM-First trial.
Although there's no magic formula for finding the appropriate pharmacy staffing levels, there are subtle shifts you can make that will have a big impact on your bottom line.
This new treatment option copackages 3 drugs for optimal treatment.
The FDA approved a biologics license application for the tick-borne encephalitis (TBE) vaccine TICOVAC for individuals 1 year or older.
The need for skilled and knowledgeable pharmacy technicians in our workforce remains steady throughout current times.
Early planning and strong partnerships enable community pharmacies to manage the surge in vaccines and treatments during flu, COVID-19, and RSV seasons.
Pharmacogenomics provides an opportunity for pharmacists to enhance their role in patient care.
Joseph DiPiro, PharmD, FCCP, FAAAS, broke down the importance of the ASHP Pharmacy Forecast and the process in which its content is curated.
A variety of nonprescription treatments, supplements, and patches can alleviate pain for children and adolescents.
This episode introduces the hosts and explores key legal issues facing independent pharmacies, including PBM terminations and state board compliance.
The increase is expected to be somewhat offset by the impact of biosimilars coming to market and more care being provided in outpatient settings.
The existing approach to disease management may be ill-suited to address the dynamic and diverse factors at play when it comes to chronic illness.
An interim FTC report outlined how the rise of vertical integration and concentration has led to devastating results for both patients and fragile pieces of the health care delivery system.
The novel drug elranatamab-bcmm (Elrexfio) received accelerated FDA approval on August 14, 2023, for treating adults with relapsed or refractory multiple myeloma.
The National Medical Products Administration in China has approved pembrolizumab for use in combination with platinum and fluoropyrimidine-based chemotherapy for the frontline treatment of patients.
A conversation with Chelsea Keedy, PharmD, BCACP, clinical assistant professor at the University of Georgia, on RSV vaccine recommendations.
With minimal pharmacological treatments coming to market for chronic pain, researchers have explored new technologies for advancing pain treatment across the globe.
Improvement across all asthma control parameters was achieved after 12 months of biologic treatment with mepolizumab, benralizumab, and omalizumab.
It’s crucial to be openminded about these approaches, and to convey accurate information to patients in a nonjudgmental manner.
Sustainable CGM counseling combines pharmacist expertise, technician support, multimodal education, and policy advocacy to improve patient outcomes in diabetes care.
In this episode, host Taylor Watterson, PharmD, PhD, welcomes Josie Quick, CPhT-Adv, CSPT, BUS, an advanced certified pharmacy technician with over 20 years of experience.
A conversation with Ginger Lemay, PharmD, Jeffrey Bratberg, PharmD, and Audrey Whalen, PharmD.
A unified data ecosystem will provide the foundation for the next generation of patient-care technology.
Tamara McCants, PharmD, president of NPhA, and Tazche Turner, PharmD, national president of SNPhA, discuss what to expect at this year’s meeting.
CMS and state officials are using payment incentives, data collection and program requirements to start edging the lofty ideals of health equity toward reality.
Jeffrey Bratberg, PharmD and Madi Hartling, a 2025 PharmD candidate, discuss the lack of pharmacists in medical shows and how pharmacists are typically portrayed negatively in media.
The 2-dose hepatitis B vaccine was not associated with a higher risk of acute myocardial infarction compared with the 3-dose hepatitis B vaccine series.
Christopher Bunick, MD, PhD, FAAD, an associate professor of dermatology and a physician-scientist at the Yale School of Medicine in New Haven, Connecticut, presented updates on benzene in BPO at the 2024 American Academy of Dermatology Annual Meeting.